BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12122023)

  • 1. Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers.
    Tawada A; Masa T; Oonuki Y; Watanabe A; Matsuzaki Y; Asari A
    Glycobiology; 2002 Jul; 12(7):421-6. PubMed ID: 12122023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel methods for the preparation and characterization of hyaluronan oligosaccharides of defined length.
    Mahoney DJ; Aplin RT; Calabro A; Hascall VC; Day AJ
    Glycobiology; 2001 Dec; 11(12):1025-33. PubMed ID: 11805075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On-line HPLC/ESI-MS separation and characterization of hyaluronan oligosaccharides from 2-mers to 40-mers.
    Volpi N
    Anal Chem; 2007 Aug; 79(16):6390-7. PubMed ID: 17608452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milligram-scale preparation and purification of oligosaccharides of defined length possessing the structure of chondroitin from defructosylated capsular polysaccharide K4.
    Volpi N
    Glycobiology; 2003 Sep; 13(9):635-40. PubMed ID: 12702669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study.
    Gao F; Cao M; Yang C; He Y; Liu Y
    J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):385-92. PubMed ID: 16544303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and inhibitory activity on hyaluronidase of fully O-sulfated hyaluro-oligosaccharides.
    Suzuki A; Toyoda H; Toida T; Imanari T
    Glycobiology; 2001 Jan; 11(1):57-64. PubMed ID: 11181562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of separated end hyaluronan oligosaccharides from leech hyaluronidase and evaluation of angiogenesis.
    Lv M; Wang M; Cai W; Hao W; Yuan P; Kang Z
    Carbohydr Polym; 2016 May; 142():309-16. PubMed ID: 26917404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic production of specifically distributed hyaluronan oligosaccharides.
    Yuan P; Lv M; Jin P; Wang M; Du G; Chen J; Kang Z
    Carbohydr Polym; 2015 Sep; 129():194-200. PubMed ID: 26050905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers.
    Volpi N
    Rapid Commun Mass Spectrom; 2007; 21(21):3459-66. PubMed ID: 17922485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometry for the characterization of unsulfated chondroitin oligosaccharides from 2-mers to 16-mers. Comparison with hyaluronic acid oligomers.
    Volpi N; Zhang Z; Linhardt RJ
    Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3526-30. PubMed ID: 18853395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and application of biologically active fluorescent hyaluronan oligosaccharides.
    Seyfried NT; Blundell CD; Day AJ; Almond A
    Glycobiology; 2005 Mar; 15(3):303-12. PubMed ID: 15496500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism for the hydrolysis of hyaluronan oligosaccharides by bovine testicular hyaluronidase.
    Kakizaki I; Ibori N; Kojima K; Yamaguchi M; Endo M
    FEBS J; 2010 Apr; 277(7):1776-86. PubMed ID: 20193045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer.
    Han W; Song L; Wang Y; Lv Y; Chen X; Zhao X
    Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatan sulfate oligosaccharides having reducing end 2, 5-anhydro-d-talose inhibit bovine testicular hyaluronidase activity.
    Kakizaki I; Koizumi H; Kobayashi T; Nakamura T; Majima M
    Carbohydr Res; 2019 Sep; 483():107754. PubMed ID: 31398613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qualitative and quantitative analysis of hyaluronan oligosaccharides with high performance thin layer chromatography using reagent-free derivatization on amino-modified silica and electrospray ionization-quadrupole time-of-flight mass spectrometry coupling on normal phase.
    Rothenhöfer M; Scherübl R; Bernhardt G; Heilmann J; Buschauer A
    J Chromatogr A; 2012 Jul; 1248():169-77. PubMed ID: 22721763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elastogenic effects of exogenous hyaluronan oligosaccharides on vascular smooth muscle cells.
    Joddar B; Ramamurthi A
    Biomaterials; 2006 Nov; 27(33):5698-707. PubMed ID: 16899292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of hyaluronan length in a hyaladherin-based assay for hyaluronan.
    Courel MN; Maingonnat C; Tranchepain F; Deschrevel B; Vincent JC; Bertrand P; Delpech B
    Anal Biochem; 2002 Mar; 302(2):285-90. PubMed ID: 11878809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hyaluronic acid oligosaccharides by direct coupling of capillary electrophoresis with electrospray ion trap mass spectrometry.
    Kühn AV; Rüttinger HH; Neubert RH; Raith K
    Rapid Commun Mass Spectrom; 2003; 17(6):576-82. PubMed ID: 12621620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix assisted laser desorption ionization-time of flight mass spectrometry analysis of hyaluronan oligosaccharides.
    Sakai S; Hirano K; Toyoda H; Linhardt RJ; Toida T
    Anal Chim Acta; 2007 Jun; 593(2):207-13. PubMed ID: 17543609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification and characterization of enzymatically produced hyaluronan with fluorophore-assisted carbohydrate electrophoresis.
    Kooy FK; Ma M; Beeftink HH; Eggink G; Tramper J; Boeriu CG
    Anal Biochem; 2009 Jan; 384(2):329-36. PubMed ID: 18948072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.